These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5917121)

  • 1. [The hormone treatment of breast carcinomas, with reference to Bar cell nucleus body findings].
    Ehlers PN; Hochberg K; Nuri M
    Bull Soc Int Chir; 1966; 25(3):293-9. PubMed ID: 5917121
    [No Abstract]   [Full Text] [Related]  

  • 2. [Suitability of sex-chromatin determination for the hormonal treatment of breast cancer].
    Krejczy K
    Pol Przegl Chir; 1966 Jun; 38(6):548-54. PubMed ID: 5963367
    [No Abstract]   [Full Text] [Related]  

  • 3. [The results of the treatment of carcinoma of the female breast with contrasexual hormones, with particular reference to Barr's nuclear body].
    Schöll A; Fischbach H; Mörl F; Rieckert H; Bohle A
    Verh Dtsch Ges Pathol; 1968; 52():426-30. PubMed ID: 4182274
    [No Abstract]   [Full Text] [Related]  

  • 4. The nuclear sex of breast cancer.
    Shirley RL
    Surg Gynecol Obstet; 1967 Oct; 125(4):737-40. PubMed ID: 6041717
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sex chromatin in different endocrine functions--clinical studies and experimental studies of animals].
    Yamana K
    Endokrinologie; 1964 Nov; 47(1):63-78. PubMed ID: 5836933
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chromatin structure in cell nuclei of breast carcinomas].
    Kallenberger A; Dolinar Z; Hagmann A
    Verh Anat Ges; 1966; 61():589-91. PubMed ID: 6001151
    [No Abstract]   [Full Text] [Related]  

  • 7. Sex chromatin (Barr body) and inflammatory carcinoma of the breast.
    Gros C; Colin C; Haehnel P
    Biomedicine; 1973 Feb; 19(2):65-7. PubMed ID: 4731980
    [No Abstract]   [Full Text] [Related]  

  • 8. [The problem of sex chromatin in carcinomas of the breast. (Current status of knowledge)].
    Di Curzio B; Alcini E; Marcellino LR; Franceschini R
    Ann Ital Chir; 1970 Nov; 45(5):865-80. PubMed ID: 5483298
    [No Abstract]   [Full Text] [Related]  

  • 9. [Individual therapy of the metastatic mammary carcinoma (author's transl)].
    Schönfelder M
    Arch Geschwulstforsch; 1980; 50(7):640-6. PubMed ID: 6263208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Excretion of hormones in patients with cancer of the breast after hormone loading with testosterone-propionate].
    Olinia AIa
    Klin Lech Zlokach Novoobraz; 1968; 11():79-92. PubMed ID: 5725417
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hormone treatment of breast cancer in the advanced phase].
    Demol R
    Brux Med; 1968 Oct; 48(10):665-9. PubMed ID: 5757971
    [No Abstract]   [Full Text] [Related]  

  • 12. [17-ketosteroid changes in breast cancer during testosterone propionate treatment].
    Mindlin SS; Smiller RR
    Vopr Onkol; 1970; 16(7):17-20. PubMed ID: 5482837
    [No Abstract]   [Full Text] [Related]  

  • 13. Adrenalectomy in the treatment of incurable carcinoma of the breast in five hundred consecutive patients.
    Sharma R; Ashikari R; Fracchia AA
    Surg Gynecol Obstet; 1980 Aug; 151(2):177-81. PubMed ID: 6250240
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of steroid receptors for hormone therapy in advanced breast cancer].
    Saul G; Wolf G
    Z Arztl Fortbild (Jena); 1981 Sep; 75(18):848-51. PubMed ID: 6285624
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anatomo-clinical aspects of breast carcinomas in relation to the problem of sex chromatin].
    Di Curzio B
    Ann Ital Chir; 1970; 45(6):1138-52. PubMed ID: 5495692
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diversity of sex chromatin in breast tumor cells].
    Sluzhinskaia ZA
    Tsitologiia; 1970 Sep; 12(9):1197-202. PubMed ID: 5515781
    [No Abstract]   [Full Text] [Related]  

  • 17. [Paradoxical hormone treatment of the mammary carcinoma and its recurrence].
    EVERS W
    Zentralbl Gynakol; 1954; 76(7):268-75. PubMed ID: 13188324
    [No Abstract]   [Full Text] [Related]  

  • 18. [Heterosexual treatment of breast cancers. (Experience of the Chirurgische Chirurgischen und Radiologischen Universitätsklinik Göttlingen)].
    Gregl A; Poppe H
    J Radiol Electrol Med Nucl; 1967 Nov; 48(11):792-5. PubMed ID: 5594029
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interrelation of the ovarian function and sex chromatin in dyshormonal breast neoplasms].
    Manuilova IA; Shirokova TA; Bukhteeva NF
    Sov Med; 1969 Aug; 32(8):53-7. PubMed ID: 5381925
    [No Abstract]   [Full Text] [Related]  

  • 20. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
    J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.